ArticleScientific reports2025
Precise detection of differential RNA editing sites across varied biological conditions using the CADRES pipeline.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
RNA editing is an important post-transcriptional modification for gene regulation and protein diversity. Detecting these modifications, especially Differential Variants on RNA (DVRs), presents significant challenges due to interference from sequencing errors and genetic variants. Currently, despite millions of A>I editing sites having been identified, a significant gap remains in identifying C>U RNA editing sites, mediated by cytidine deaminases, which target both DNA and RNA. To improve the detection and analysis of C>U RNA editing sites, we developed the Calibrated Differential RNA Editing Scanner (CADRES), an analytical pipeline that combines sophisticated DNA/RNA variant calling with detailed statistical analysis on depth of RNA editing. This study validates CADRES through rigorous in silico and experimental datasets using inducible cell models of the APOBEC3B (A3B) deaminase. CADRES demonstrates improved specificity and accuracy over existing methodologies, effectively identifying A3B-mediated C>U edits while filtering against sequencing artefacts and A3B-mediated DNA mutations. Our findings demonstrate that CADRES provides a reliable tool for the precise identification of C>U RNA editing sites, which will help understand the molecular mechanisms underlying cytidine deamination on RNA and its functions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.